MiNK Therapeutics Inc (NASDAQ:INKT) does about 7.55K shares in volume on a normal day but saw 47504750 shares change hands in the recent trading day. The company now has a market cap of 255.76M USD. Its current market price is $64.17, marking an increase of 730.14% compared to the previous close of $7.73. The 52 week high reached by this stock is $13.79 whilst the lowest price level in 52 weeks is $4.56.
MiNK Therapeutics Inc (INKT) has a 20-day trading average at $10.20 and the current price is 365.34% off the 52-week high compared with 1307.21% distance from its 52-week low. The 50-day simple moving average of the closing price is $8.46 and its 200-day simple moving average is $7.98. If we look at the stock’s price movements over the week, volatility stands at 59.93%, which decreases to 17.72% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 98.11 to suggest the stock is overbought.
The consensus objective for the share price is $35.00, suggesting that the stock has a potential downside of -83.34% over the period.
The current price level is 529.14%, 658.48%, and 704.02% away from its SMA20, SMA50, and SMA200 respectively, with the INKT price moving below the 50-day SMA on current market day. MiNK Therapeutics Inc (INKT) stock is up 787.38% over the week and 746.77% over the past month. Its price is 620.53% year-to-date and 820.79% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -83.34 percent from here.
The beta has a value of 0.19.